A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled “Imipridones ONC201/ONC206 + RT/TMZ ...

A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ ...

Boston College researchers contribute to new report on using a ketogenic diet to combat an aggressive brain tumor A British man who rejected the standard of care to treat his brain cancer has lived ...

Early results show that the combination of VXM01 plus avelumab demonstrated tolerable safety in recurrent glioblastoma.

Our findings demonstrate for the first time that IRT therapy combining ONC201 or ONC206 with RT and TMZ may be a safe and effective therapeutic ...

Glioblastoma (GBM), one of the most aggressive types of brain cancer, is one of the greatest challenges for medicine, both because it is difficult to treat and because of its high mortality rate.

Shares of OSR Holdings more than doubled after the company's Vaximm subsidiary announced final data from its Phase 2a clinical trial of VXM01 with avelumab, a drug combination aimed at treating ...